Infant Neutropenia Associated with Breastfeeding During Maternal Antiretroviral Treatment for Prevention of Mother-to-Child Transmission of HIV
Maternal antiretroviral treatment (ART) is recommended for prevention of mother-to-child HIV-1 transmission (PMTCT), including in women with high CD4 cell counts. Within a pediatric HIV-1 vaccine trial PedVacc 002, we assessed hematologic profiles of infants born to mothers receiving ART. All mother...
Saved in:
Published in | Retrovirology : Research and Treatment Vol. 2014; no. 6; pp. 1 - 5 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
SAGE Publishing
2014
Sage Publications Ltd. (UK) Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Maternal antiretroviral treatment (ART) is recommended for prevention of mother-to-child HIV-1 transmission (PMTCT), including in women with high CD4
cell counts. Within a pediatric HIV-1 vaccine trial PedVacc 002, we assessed hematologic profiles of infants born to mothers receiving ART. All mothers had CD4
cell counts of >350 mm
; 93% received zidovudine-containing ART; infants received nevirapine up to 6 weeks and cotrimoxazole after 6 weeks. Among 84 infants at 19 weeks, 58% had hematologic toxicity; 44% had neutropenia and 23% had anemia. Breastfeeding was associated with 3.8-fold higher risk of neutropenia (RR 3.8, 95% CI 1.03-14.1, p = 0.008). Hematologic monitoring and PMTCT regimen selection are important for optimizing infant outcomes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Conceived and designed the experiments: IN, MR, TH, GJ-S. Analyzed the data: MR and IN. Wrote the first draft of the manuscript: IN. Contributed to the writing of the manuscript: IN, MR, TH, GJ-S. Agree with manuscript results and conclusions: IN, MR, WJ, CG, GA, EM-O, BL-P, TH, and GJ-S. Jointly developed the structure and arguments for the paper: IN, MR, TH, G J-S. Made critical revisions and approved final version: IN, MR, WJ, CG, GA, EM-O, BL-P, TH, and GJ-S. All authors reviewed and approved of the final manuscript. Author Contributions |
ISSN: | 1178-1238 1178-1238 |
DOI: | 10.4137/RRT.S13267 |